Progression-Free Survival Gain: A Reliable Primary End Point for Drug Registration That Can Accelerate Patient Access to Urgently Needed Therapies.

Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)

Keyphrases